Clinical trial
Pilot Feasibility Study of Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
NCT03987555 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Pilot Feasibility Study of Paclitaxel Therapeutic Drug Monitoring in Cancer Patients
- Lead sponsor
- Wake Forest University Health Sciences
- Phase
- Observational
- Overall status
- Suspended
- Start date
- November 11, 2019
- Completion date
- May 31, 2027
- Enrollment
- 55 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
anatomic stage iv breast cancer ajcc v8, invasive breast cancer, malignant uterine neoplasm, metastatic breast carcinoma, metastatic cervical carcinoma, metastatic nonsmall cell lung cancer, metastatic ovarian carcinoma, prognostic stage iv breast cancer ajcc v8, recurrent breast carcinoma, recurrent cervical carcinoma, recurrent lung non-small cell carcinoma, recurrent ovarian carcinoma, recurrent vulvar carcinoma, solid tumor, adult, stage iv cervical cancer ajcc v8, stage iv lung cancer ajcc v8, stage iv ovarian cancer ajcc v8, stage iv vulvar cancer ajcc v8, stage iva cervical cancer ajcc v8, stage iva lung cancer ajcc v8, stage iva ovarian cancer ajcc v8, stage iva vulvar cancer ajcc v8, stage ivb cervical cancer ajcc v8, stage ivb lung cancer ajcc v8, stage ivb ovarian cancer ajcc v8, stage ivb vulvar cancer ajcc v8, vulva squamous cell carcinoma, vulvar cancer